Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
NCT 04106492 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 04106492 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 05886868 Brief Summary This is the first in human study of…
Read more arrow_forwardNCT 04262466 Brief Summary Brenetafusp (IMC-F106C) is an immune-mobilizing monoclonal T cell…
Read more arrow_forwardACTRN 12621001537842 Brief Summary This trial aims to determine whether NOX66 (idronoxil)…
Read more arrow_forwardNCT 05544552 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 04450732 Brief Summary Phase I Dose Finding Study for GQ1001 in…
Read more arrow_forwardACTRN 12623001216606 Brief Summary The purpose of the study is to investigate…
Read more arrow_forwardNCT 06736704 Brief Summary This study is testing a new medicine, SNV4818,…
Read more arrow_forwardNCT 05614258 Brief Summary ADG206 is an activatable prodrug form of a…
Read more arrow_forwardNCT 05267626 Brief Summary This is a first in human, open-label, multi-center…
Read more arrow_forward